Terms: = Ovarian cancer AND ABL2, ARG, 27, ENSG00000143322, P42684, ABLL, RP11-177A2_3 AND Diagnosis
5576 results:
1. Hybrid chain reaction and selective recognition-based homogeneous dual-fluorescence analysis of circulating tumor cells in clinical ovarian cancer samples.
Hu Q; Tang D; Li M; Liang X; Zhou J; Meng Y; Wei Y; Yan S; Lin R; Niu X; Zhang L
Anal Chim Acta; 2023 Nov; 1281():341877. PubMed ID: 38783734
[TBL] [Abstract] [Full Text] [Related]
2. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
[TBL] [Abstract] [Full Text] [Related]
3. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
Gao L; Fan J; He J; Che X; Wang X; Han C
Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract] [Full Text] [Related]
5. Circular RNA circMAN1A2 promotes ovarian cancer progression through the microRNA-135a-3p/IL1RAP/TAK1 pathway.
Li B; Hu C; Zhao D; Nie M; Wang X
PeerJ; 2024; 12():e16967. PubMed ID: 38680890
[TBL] [Abstract] [Full Text] [Related]
6. High-Grade Serous ovarian cancer during Pregnancy: From diagnosis to Treatment.
Vivod G; Merlo S; Kovacevic N
Curr Oncol; 2024 Apr; 31(4):1920-1935. PubMed ID: 38668047
[TBL] [Abstract] [Full Text] [Related]
7. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
[TBL] [Abstract] [Full Text] [Related]
8. Granulosa cell tumor of the ovary: a series of 6 cases.
da Costa REAR; Silva MCA; Cavalcante ECX; Branco ROC; Dos Reis CA; Vieira SC
Pan Afr Med J; 2024; 47():58. PubMed ID: 38646138
[TBL] [Abstract] [Full Text] [Related]
9. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
10. Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
Symons R; Heath F; Duggan J; Bui KT; Byun L; Friedlander M; Lee YC
Support Care Cancer; 2024 Apr; 32(5):292. PubMed ID: 38632132
[TBL] [Abstract] [Full Text] [Related]
11. Imaging for local recurrence of breast cancer.
Schlaiss T; Bott L; Herbert SL; Bartmann C; Kiesel M; Salmen J; Sauer ST; Christner SA; Petritsch B; Grunz JP; Woeckel A; Löb S; Diessner J
J Cancer Res Clin Oncol; 2024 Apr; 150(4):200. PubMed ID: 38627285
[TBL] [Abstract] [Full Text] [Related]
12. Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.
Chen Z; Wang C; Ding J; Yu T; Li N; Ye C
PLoS One; 2024; 19(4):e0291149. PubMed ID: 38603733
[TBL] [Abstract] [Full Text] [Related]
13. Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancer.
Kallio HM; Savolainen K; Virtanen T; Ryyppö L; Selin H; Martikainen P; Staff S; Kivinummi K; Sipola J; Vuorinen J; Nikkola J; Nykter M; Auranen A; Annala M
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38580393
[TBL] [Abstract] [Full Text] [Related]
14. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
17. Development and validation of an interpretable model integrating multimodal information for improving ovarian cancer diagnosis.
Xiang H; Xiao Y; Li F; Li C; Liu L; Deng T; Yan C; Zhou F; Wang X; Ou J; Lin Q; Hong R; Huang L; Luo L; Lin H; Lin X; Chen H
Nat Commun; 2024 Mar; 15(1):2681. PubMed ID: 38538600
[TBL] [Abstract] [Full Text] [Related]
18. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
Alwafai Z; Beck MH; Fazeli S; Gürtler K; Kunz C; Singhartinger J; Trojnarska D; Zocholl D; Krankenberg DJ; Blohmer JU; Sehouli J; Pietzner K
BMC Cancer; 2024 Mar; 24(1):380. PubMed ID: 38528468
[TBL] [Abstract] [Full Text] [Related]
19. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
20. A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device.
Natarajan P; Martha Schofield A; Elena Vinturache A; Ruthven S; Lane S; Duncan Macdonald R
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():311-315. PubMed ID: 38518485
[TBL] [Abstract] [Full Text] [Related]
[Next]
